VaDrugDiscoveryRx 2022: Cardiovascular, Pulmonary, and Metabolic Disease

Tue, May 24, 2022, 1:00 PM – Wed, May 25, 2022, 4:00 PM EDT

VaDDRx 2022 will feature lectures from leaders in the fields of cardiovascular, pulmonary, and metabolic disease.


Virginia Drug Discovery Consortium

The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:

To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.

To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.

To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.


Desai Grant on Factor XIa Inhibitors Funded

Desai Grant on Factor XIa Inhibitors Funded

Umesh Desai, VaDDC executive committee member and chair of Virginia Commonwealth University's medicinal chemistry department, has just received an R61/33 grant to develop allosteric inhibitors of coagulation factor XIa.  The grant, titled "Lead Identification and...

read more


Virginia Tech
Virginia Biosciences Health Research Corporation

Want to work with us?

If you are interested in supporting this initiative, please contact us.